• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Oncology
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
    • Oncology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Oncology
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
    • Oncology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

cannabinoids

Long haired red satin mouse on scales
Research

Artelo cannabinoid agonist holds its own against semaglutide

Artelo’s ART27.13 in combination with semaglutide, showed double the weight loss compared with semaglutide alone.
Marissa Russo Sep 18, 2026 2:22pm
Completing steps towards success checkmark on cubes symbolizing progress

Corbus posts obesity data in area where Novo, Sanofi stumbled

Sep 14, 2026 10:07am
MA strategy deal block push come together form

Mira seeks to buy Skny for obesity, smoking cessation asset

Mar 24, 2025 10:08am
Graphic of two hands shaking under a red and purple light

Polyrizon pays $3M for license to SciSparc's CB2R agonist

Aug 19, 2024 5:27am
Novo Nordisk

Novo Nordisk bets $1B on biotech buyout to grow obesity pipeline

Aug 10, 2023 6:30am
graphic of a bed illuminated atop a cloud

Fortrea inks deal with Incannex for sleep apnea drug trial

Jul 27, 2023 9:28am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings